Ethyl 5-chloroimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 5g

3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride, 98%, 25mg

tert-Butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate, 97%, 50mg

1-(4-(BENZYLOXY)CYCLOHEXYL)-2-(5H-IMIDAZO[5,1-A]ISOINDOL-5-YL)ETHANOL, 90.0%, 250mg

1,1,4,4-Tetramethyl-1,2,3,4-tetrahydronaphthalene, 95.0%, 25g

N'-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide, 95.0%, 25g

L-Proline>99.0%(HPLC)(T)25g

2-(Dicyclohexylphosphino)-2',4',6'-tri-isopropyl-1,1'-biphenyl, 98.0%, 100g

(4-Bromopyridin-2-yl)methanol, 95.0%, 1g

4-Methylheptan-2-one, 95%, 1g

1H-INDAZOLE-4-CARBOXYLIC ACID, 5-BROMO-6-FLUORO-, METHYL ESTER, 95%, 100mg

Fmoc-NH-PEG8-NHS ester, 100mg

(R)-3-(3-(Allyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 100mg